SEC Comment Letter 0000000000-24-011545 to Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788) (GLSI)
Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788)
Date: Oct. 11, 2024 · CIK: 0001799788 · Accession: 0000000000-24-011545
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282533
Letter
October 11, 2024 Snehal Patel Chief Executive Officer Greenwich LifeSciences, Inc. 3992 Bluebonnet Dr., Building 14 Stafford, TX 77477 Re:Greenwich LifeSciences, Inc. Registration Statement on Form S-3 Filed October 7, 2024 File No. 333-282533 Dear Snehal Patel: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Jeffrey J. Fessler, Esq.
Show Raw Text
October 11, 2024
Snehal Patel
Chief Executive Officer
Greenwich LifeSciences, Inc.
3992 Bluebonnet Dr., Building 14
Stafford, TX 77477
Re:Greenwich LifeSciences, Inc.
Registration Statement on Form S-3
Filed October 7, 2024
File No. 333-282533
Dear Snehal Patel:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Jeffrey J. Fessler, Esq.